Press "Enter" to skip to content

New patent for Acerus drug NATESTO

0
Copyright © DrugPatentWatch. Originally published at New patent for Acerus drug NATESTO

Annual Drug Patent Expirations for NATESTO
Annual Drug Patent Expirations for NATESTO

Natesto is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has twenty-four patent family members in twenty-one countries.

The generic ingredient in NATESTO is testosterone. One supplier is listed for this compound. Additional details are available on the testosterone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Acerus drug NATESTO
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions